Exploring gut bacteria in pancreatic cancer tumors
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial studies bacteria found inside pancreatic tumors to see if they can help diagnose or predict the course of the disease. You may be eligible if you have a suspected pancreatic cancer and need a special biopsy (EUS-FNB).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- Imaging tests (like CT or MRI) show a growth in your pancreas that may be cancer.
- You have not had any chemotherapy yet (before or after surgery).
- You agree to take part and sign a consent form.
- You are not currently taking antibiotics for an infection.
- You do not have severe health problems like anemia or heart/lung issues.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the bacteria living in your gut and pancreas to understand how they might affect pancreatic cancer and precancerous changes. It is for people who are already scheduled for an endoscopic procedure to look at or treat a pancreatic lesion.
This study uses small pancreatic cancer samples grown in the lab to understand which treatments may work best for people with pancreatic cancer. It may help researchers better “profile” tumors so standard care can be matched to the most effective options.
This study follows how pancreatic cancer changes over time while you’re receiving treatment before surgery. It may help doctors understand how the cancer evolves and guide better future treatment choices.
This trial uses a special ultrasound test to collect cells from a pancreatic tumor and study them to better predict if the cancer may come back or spread. It aims to help doctors choose the best treatment plan for each person.
This study looks at blood markers and gut bacteria to better understand the risk of pancreatic cancer in people with chronic pancreatitis (long-term pancreas inflammation). It may help detect cancer earlier or guide prevention.
This trial studies metastatic pancreatic cancer by taking a small tissue sample and analyzing its genes. It may help doctors better understand which cancer subtypes patients have, which can guide future treatment choices.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.